Table 1.
-1 week | 0 week | 3 weeks | 6 weeks | 3 weeks after treatment | 6 weeks after treatment | |
---|---|---|---|---|---|---|
|
Baseline |
Treatment phase |
Follow-up phase |
|||
Patients |
X |
|
|
|
|
|
Informed consent |
x |
|
|
|
|
|
Medical history |
x |
|
|
|
|
|
Physical examination |
|
x |
|
|
|
|
Randomization |
|
|
|
|
|
|
Intervention |
|
|
|
|
|
|
Affected meridian acupuncture group (n = 107) |
|
18 sessions of acupuncture at acupoints |
|
|
||
Non-affected meridian acupuncture group (n = 107) |
|
|
|
|||
Comparisons |
|
|
|
|
|
|
Incasive sham acupuncture group (n = 107) |
|
18 sessions of acupuncture at non-acupoints |
|
|
||
Waiting-list group (n = 107) |
|
18 sessions of treatment at the end of the trial |
|
|
||
Outcomes |
|
|
|
|
|
|
24-h blood pressure |
|
x |
|
x |
x |
x |
Expectation of acupuncture |
|
x |
|
|
|
|
SF- 36 |
|
x |
|
x |
|
|
Response to treatment |
|
|
|
x |
|
|
Participants safety |
|
|
|
|
|
|
Laboratory test |
|
x |
|
|
|
|
Adverse events | x | x | x | x | x |
SAS, Self-Rating Anxiety Scale; SDS, Self-Rating Depression Scale; SF-36, MOS item Short Form health survey.